DK1656358T3 - Stabil polymorf af bifeprunox-mesilat - Google Patents

Stabil polymorf af bifeprunox-mesilat

Info

Publication number: DK1656358T3
Authority: DK; Denmark
Prior art keywords: stable polymorph; bifeprunox; mesilate; bifeprunox mesilate; polymorph
Prior art date: 2003-08-18

Application number

DK04766517.9T

Other languages

English (en)

Inventor

Klaas Zwier

Gerrit Klein

Irene Eijgendaal

Horst-Van Amstel Maria J L Ter

Original Assignee

Abbott Healthcare Products Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-18

Filing date

2004-08-18

Publication date

2011-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1656358(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-08-18 Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv

2011-05-30 Application granted granted Critical

2011-05-30 Publication of DK1656358T3 publication Critical patent/DK1656358T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)

DK04766517.9T 2003-08-18 2004-08-18 Stabil polymorf af bifeprunox-mesilat DK1656358T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US49570803P	2003-08-18	2003-08-18
EP03102573		2003-08-18
PCT/EP2004/051816 WO2005016898A2 (en)	2003-08-18	2004-08-18	Stable polymorph of bifeprunox mesilate

Publications (1)

Publication Number	Publication Date
DK1656358T3 true DK1656358T3 (da)	2011-05-30

Family

ID=34924088

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04766517.9T DK1656358T3 (da)	2003-08-18	2004-08-18	Stabil polymorf af bifeprunox-mesilat

Country Status (26)

Country	Link
EP (1)	EP1656358B1 (da)
JP (1)	JP2007502802A (da)
CN (1)	CN100422159C (da)
AR (1)	AR045362A1 (da)
AT (1)	ATE499348T1 (da)
AU (1)	AU2004265104B2 (da)
BR (1)	BRPI0413617A (da)
CA (1)	CA2536149C (da)
DE (1)	DE602004031534D1 (da)
DK (1)	DK1656358T3 (da)
EA (1)	EA008182B1 (da)
ES (1)	ES2361508T3 (da)
IS (1)	IS8279A (da)
ME (1)	MEP37108A (da)
MX (1)	MXPA06001881A (da)
MY (1)	MY139462A (da)
NO (1)	NO20061265L (da)
NZ (1)	NZ545415A (da)
PL (1)	PL1656358T3 (da)
PT (1)	PT1656358E (da)
RS (1)	RS20060113A (da)
SI (1)	SI1656358T1 (da)
TW (1)	TWI336695B (da)
UA (1)	UA85562C2 (da)
WO (1)	WO2005016898A2 (da)
ZA (1)	ZA200601399B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7423040B2 (en) *	2005-02-18	2008-09-09	Irene Eijgendaal	Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
CA2654557A1 (en) *	2006-06-16	2007-12-21	Solvay Pharmaceuticals B.V.	Combination preparations comprising bifeprunox and l-dopa
EA200970239A1 (ru)	2006-08-31	2009-08-28	Солвей Фармасьютикалс Б.В.	Режим титрования бифепрунокса для лечения шизофрении и наборы для применения в этой области
WO2011023796A1 (en)	2009-08-31	2011-03-03	Abbott Healthcare Products B.V.	Bifeprunox for treating addiction
US9675101B2 (en)	2013-03-15	2017-06-13	Whirlpool Corporation	High performance adjustable juicer with whole foods feed chute

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE340173T1 (de) *	1996-03-29	2006-10-15	Duphar Int Res	Piperazin- und piperidin- derivate
IL127497A (en) *	1997-12-18	2002-07-25	Pfizer Prod Inc	Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders
AU2003999A (en) *	1997-12-19	1999-07-12	Advanced Research And Technology Institute, Inc.	Modulators of ryanodine receptors comprising 2-(aryl)-4,7-dioxobenzothiazoles and analogues thereof
AR034206A1 (es) *	2001-02-16	2004-02-04	Solvay Pharm Bv	Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos

2004
- 2004-08-13 AR ARP040102906A patent/AR045362A1/es unknown
- 2004-08-16 TW TW093124532A patent/TWI336695B/zh not_active IP Right Cessation
- 2004-08-16 MY MYPI20043324A patent/MY139462A/en unknown
- 2004-08-18 DK DK04766517.9T patent/DK1656358T3/da active
- 2004-08-18 WO PCT/EP2004/051816 patent/WO2005016898A2/en not_active Ceased
- 2004-08-18 MX MXPA06001881A patent/MXPA06001881A/es active IP Right Grant
- 2004-08-18 DE DE602004031534T patent/DE602004031534D1/de not_active Expired - Lifetime
- 2004-08-18 EA EA200600442A patent/EA008182B1/ru not_active IP Right Cessation
- 2004-08-18 JP JP2006523633A patent/JP2007502802A/ja active Pending
- 2004-08-18 RS YUP-2006/0113A patent/RS20060113A/sr unknown
- 2004-08-18 PT PT04766517T patent/PT1656358E/pt unknown
- 2004-08-18 ES ES04766517T patent/ES2361508T3/es not_active Expired - Lifetime
- 2004-08-18 SI SI200431663T patent/SI1656358T1/sl unknown
- 2004-08-18 EP EP04766517A patent/EP1656358B1/en not_active Expired - Lifetime
- 2004-08-18 ME MEP-371/08A patent/MEP37108A/xx unknown
- 2004-08-18 CN CNB2004800235660A patent/CN100422159C/zh not_active Expired - Fee Related
- 2004-08-18 NZ NZ545415A patent/NZ545415A/en not_active IP Right Cessation
- 2004-08-18 AU AU2004265104A patent/AU2004265104B2/en not_active Ceased
- 2004-08-18 BR BRPI0413617-9A patent/BRPI0413617A/pt not_active IP Right Cessation
- 2004-08-18 CA CA2536149A patent/CA2536149C/en not_active Expired - Fee Related
- 2004-08-18 PL PL04766517T patent/PL1656358T3/pl unknown
- 2004-08-18 AT AT04766517T patent/ATE499348T1/de active
- 2004-08-18 UA UAA200602994A patent/UA85562C2/ru unknown
2006
- 2006-01-31 IS IS8279A patent/IS8279A/is unknown
- 2006-02-16 ZA ZA200601399A patent/ZA200601399B/en unknown
- 2006-03-20 NO NO20061265A patent/NO20061265L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2005016898A2 (en)	2005-02-24
SI1656358T1 (sl)	2011-06-30
RS20060113A (sr)	2008-09-29
EA200600442A1 (ru)	2006-08-25
NZ545415A (en)	2009-11-27
AU2004265104A1 (en)	2005-02-24
TWI336695B (en)	2011-02-01
BRPI0413617A (pt)	2006-10-17
PL1656358T3 (pl)	2011-07-29
MY139462A (en)	2009-10-30
PT1656358E (pt)	2011-05-12
CN1835935A (zh)	2006-09-20
TW200513462A (en)	2005-04-16
CA2536149A1 (en)	2005-02-24
AU2004265104B2 (en)	2009-06-04
DE602004031534D1 (de)	2011-04-07
ATE499348T1 (de)	2011-03-15
NO20061265L (no)	2006-05-09
JP2007502802A (ja)	2007-02-15
UA85562C2 (en)	2009-02-10
CN100422159C (zh)	2008-10-01
IS8279A (is)	2006-01-31
MEP37108A (en)	2011-02-10
MXPA06001881A (es)	2006-05-17
ZA200601399B (en)	2007-04-25
EP1656358B1 (en)	2011-02-23
AR045362A1 (es)	2005-10-26
WO2005016898A3 (en)	2005-04-07
CA2536149C (en)	2011-03-22
WO2005016898B1 (en)	2005-05-19
ES2361508T3 (es)	2011-06-17
EA008182B1 (ru)	2007-04-27
EP1656358A2 (en)	2006-05-17

Publication	Publication Date	Title
NO20220690A1 (no)	2007-02-07	Stabil krystall av 4-oxoquinolinforbindelse
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK1476162T3 (da)	2007-07-02	Kontrolleret syntese af ziprasidone
DK1658295T3 (da)	2007-09-24	Regioselektiv syntese af CCI-779
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
DK3395338T3 (da)	2019-07-22	Hurtigt opløsende formulering af cinacalcet-hcl
DK1438306T3 (da)	2014-06-23	Derivater af UK-2A
DK1992697T3 (da)	2010-05-17	Fremstilling af TNFR-Fc
DK2377869T3 (da)	2014-04-14	Syntese af Bortezomib
DK1763673T3 (da)	2014-07-28	Anvendelser af gelformuleringer
DK1360169T3 (da)	2007-11-26	Succinatsalt af O-desmethyl-venlafaxin
CY2017048I1 (el)	2018-09-05	Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
DK1417180T3 (da)	2007-04-10	Fremstilling af aminopyrimidinforbindelser
DK2402005T3 (da)	2021-03-15	Formuleringer med langvarig frigivelse af nalbuphin
DK1587542T3 (da)	2012-07-30	Anvendelse af anti-CD100-antistoffer
DK1516540T3 (da)	2012-11-26	Anvendelse af vitamin D-forbindelser
DK1401828T3 (da)	2006-07-31	N-Formylhydroxylaminforbindelser som inhibitorer af PDF
NO20054762D0 (no)	2005-10-17	Polymorphs of aripiprazole
CR9144A (es)	2007-11-23	Formulaciones de benzoxazoles sustituidos
DK1827483T3 (da)	2014-10-06	Terapeutiske formuleringer af keratinocyt-vækstfaktor
NO20043305D0 (no)	2004-08-09	Preparation of lodixanol
DK1578774T3 (da)	2014-02-03	Oprensning af immunoglobuliner
IS8399A (is)	2006-04-05	Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns
DK1744781T3 (da)	2012-10-15	Behandling af infektionssygdomme
DK1656358T3 (da)	2011-05-30	Stabil polymorf af bifeprunox-mesilat